Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin plus standard chemotherapy in newly diagnosed T-cell lymphoma (phase II)
KCT0007442Phase 2Not yet recruiting
- Sponsor
- Yuhan
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of metformin in T-cell lymphoma, sponsored by Yuhan. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
metformin
03
Conditions
T-cell lymphoma
Beyond the preview
Go deeper on KCT0007442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007442.